Days in AR Reduction Strategies for Independent Practices

Days in AR is a formula: total accounts receivable divided by average daily charges. It's an average, not a ceiling or a floor, and a healthy-looking number can hide a claim base that's quietly aging into write-off territory. This piece walks through why AR days drift, where the drift actually starts, and how to sequence the fix so each step builds on the last instead of chasing balances after the damage is done.

A practice at 38 days, comfortably inside the MGMA benchmark range of 30 to 40 days, can still have a quarter of its total AR sitting in claims older than 90 days. That concentration, not the headline average, is where money disappears for good. Payer timely filing limits don't care about your average. Once a deadline passes, an aged claim converts from delayed to written off, and no amount of a healthy top-line number changes that.

Before any strategy gets applied, the number itself needs a hard look, because most practices are measuring it wrong. Resetting claim age every time a claim gets resubmitted makes the aging look healthier than it is: the clock restarts instead of reflecting how long the money has actually been outstanding. Leaving patient bad debt inside the AR calculation inflates the figure; the billing team's performance and the dead weight it was never going to collect become indistinguishable. And charge lag, the week or so between the date of service and the date the claim goes out, means a claim can already be old before anyone on the billing side has even touched it.

Days in AR is a lagging indicator. It reflects decisions made weeks earlier, at eligibility check, at the coding desk, in the prior authorization queue. Chasing aged balances after the fact is the least efficient point of intervention a practice has available to it, and treating the sub-40 MGMA range as an acceptable resting place is a mistake. Top performers hold under 30 days, and that gap is the whole argument for reading further.

Why AR days have drifted upward in 2026

Industry-wide, AR days climbed by a median of 2.4 days in 2026. The driver sits in Medicare Advantage prior authorization backlogs and claims pended for medical record review, sitting in payer queues longer than they used to.

Three specialties absorbed nearly the entire increase: cardiology, orthopedics, and oncology. That's not a coincidence. These are the specialties carrying the heaviest prior authorization burden, where a single pended claim can mean months of imaging, staging, or surgical planning waiting on a payer decision.

Payers say they're moving the other direction, and the paper trail backs that up on its face. Major commercial payers and Medicare Advantage plans committed to shrinking their prior authorization lists between 2025 and 2026, and some report real progress: an 11% reduction in prior authorizations overall and over 15% within Medicare Advantage specifically by early 2026. UnitedHealthcare shortened its peer-to-peer review request window from 30 days to 14 days from the denial date. Humana's Medicare Advantage plans stay anchored to the CMS-mandated 72-hour window for expedited appeals on urgent authorization requests.

So the rules are getting faster on paper while the results get slower in practice, and the gap between those two facts is where the real story sits. The AMA's 2025 Prior Authorization Survey found that algorithmic denial decisions now return in hours, but carry denial rates 40% higher than decisions a human reviewer made. Speed and accuracy pulled in opposite directions, and speed won. That's the actual mechanism behind the drift: faster review queues stacked with more denials, not fewer.

A 10-day reduction in AR on a $5 million practice frees up roughly $137,000 in working capital. Read in reverse, a 2.4-day industry-wide drift is real cash pulled straight out of practice operations, every year, on repeat. Zoomed out to hospitals, U.S. hospitals lost $48.4 billion to revenue leakage in 2025, a 25% jump from the year before. That's hospital data, not independent practice data, but the direction of travel is the same at every level of care delivery.

The denial rate data that shows where days in AR originates

Denial rates in 2026 average 8 to 12% industry-wide, and best-in-class practices hold below 5%. That gap almost never comes down to staffing levels, and blaming the billing team for a bad denial rate points the finger at the wrong desk. It comes down to what happens before the claim ever leaves the building.

The trend is a slope, not a single bad stretch. The Experian State of Claims Report 2025 found that initial denial rates climbed from 10.2% in 2020 to 11.8% in 2024, a steady year-over-year climb. Experian Health's 2025 survey, fielding 250 healthcare revenue cycle leaders, found that 41% of providers now report more than 10% of their claims denied, up from 38% in 2024 and 30% in 2022. Asked what's driving it, those same leaders point upstream: half named missing or inaccurate claim data, over a third cited missing authorization, and nearly a third named registration data errors.

None of that is cheap to fix after the fact. The administrative cost of reworking a single denied claim rose from $43.84 in 2022 to $57.23 in 2023, and that cost lands on every claim that should have been caught before submission.

Denial rate looks like a back-end metric sitting on a dashboard somewhere, and that framing is exactly backwards. It's the accumulated result of every decision made before a claim left the practice: who verified eligibility, who checked the modifier, who confirmed the authorization was on file.

The three upstream failure points that drive most denial-related AR aging

Each of the three failure points below maps to a predictable aging bucket. The damage is traceable before it becomes a write-off, if someone's actually looking.

Eligibility and coordination-of-benefits gaps aren't visible at registration, because the mismatch sits with the payer's records, not the practice's own front desk. Because the mismatch sits with the payer's records, not the practice's own front desk, denials appear only once a claim is sitting in a payer's queue, becoming visible in the 31-to-60-day aging bucket well after the visit happened. Survey data consistently identifies patient information errors as a primary cause of denials. The fix isn't complicated in concept: verify eligibility in real time, 2 to 3 days before the visit, not at the check-in desk five minutes before the appointment.

Coding and modifier mismatches trip National Correct Coding Initiative bundling edits or payer-specific edits, and the claim bounces back for rework, often landing past the 60-day mark by the time it's resolved. CO-97 bundling denials and CO-50 denials for lack of medical necessity are the codes to watch for. A pre-submission coding audit against payer-specific edit sets, run before the claim ever leaves the practice, catches most of this before it turns into rework.

Missing or incomplete prior authorization is the most expensive failure of the three, and practices treat it as a billing problem when it's actually a scheduling one. It doesn't stall a claim in the 31-to-60-day bucket the way eligibility gaps do. It sends the claim straight into the 90-plus-day bucket. A CO-197 denial for missing authorization belongs to whoever confirmed the appointment, not whoever billed for it, and the fix has to live there: authorization verification built into the scheduling workflow before the appointment gets confirmed.

Documentation gaps compound all three. Payers in 2026 increasingly expect notes that tie diagnosis, symptoms, and treatment plan together in plain, defensible language, not shorthand that assumes the reviewer will fill in the gaps. Appeals for medical necessity can stretch AR aging past 120 days, and the structural fix is documentation templates built around local coverage determination criteria, so the note answers the payer's question before it gets asked.

Untimely filing is the terminal failure on this list. Once the deadline passes, the claim converts from recoverable to gone. No appeal, no resubmission, no escalation brings that money back, and every dollar in that bucket is a dollar the practice should have caught weeks earlier.

Root-cause denial analysis as a cycle, not a one-time audit

The method itself isn't complicated. Pull every denial from the trailing 90 days, sort by CARC and RARC code, payer, and CPT code, and ask one question for each claim: what upstream step failed?

Rework and root cause get treated as interchangeable, and that's the wrong instinct. Rework corrects the claim, resubmits it, and moves on, treating the symptom without asking why it appeared. Root cause analysis asks why that denial pattern keeps recurring for that payer and that procedure code, then fixes the step that produced it. A denial rate holding steady month after month despite staff working harder is the signature of a rework-only culture, not a broken team, and mistaking one for the other wastes a year of effort.

The CARC and RARC codes are a map, once someone reads them that way. Missing authorization, CO-197, implicates the scheduling workflow. CO-16 paired with an eligibility RARC points straight at the front desk verification step. CO-97, bundling, points to coding or modifier logic. Broken out by payer and procedure code, the fix targets the specific step that's actually broken instead of throwing a generic retraining session at an entire team that mostly did nothing wrong.

The discipline has to run weekly, not quarterly. Tracking claim-aging buckets, denial rate by payer, first-pass resolution rate, and AR over 90 days on a weekly cadence catches problems while they're still cheap to fix. Under a monthly or quarterly review cycle, a denial spike that starts in March doesn't register as a cash shortfall until weeks later, and that lag is the hidden cost of infrequent monitoring. Tracking AR older than 90 days against an established internal ceiling is a number that only becomes useful once someone's watching it every week instead of once a quarter.

Practices that run root-cause analysis as a standing weekly cycle, rather than a periodic audit, are the ones that move toward the lower end of the standard 30-to-40-day range that top performers hold.

The KPI set that gives practices an early warning before AR days drift

Days in AR moves last. The metrics that lead it belong on a dashboard, tracked in real time, and eight of them qualify.

Clean claim rate should sit above 95% on first submission. First-pass resolution rate tracks claims paid without any rework. Denial rate belongs below 5% for practices aiming at best-in-class performance. Net collection rate should run 95% to 99% for multi-specialty groups, with top performers landing between 98% and 100%. Cost to collect deserves attention because a rising figure signals process trouble before AR days ever move, an earlier warning than the lagging aggregate itself. Charge lag days should stay as short as possible from date of service; anything beyond a day or two starts the AR clock before the billing team has even engaged with the claim. Patient collection rate deserves its own line, since industry data reported that insured patient yield dropped from 45.1% in 2024 to 42.4% in 2025, a growing share of total AR exposure rather than a shrinking one.

If AR days climb above 45, the diagnostic order matters. Audit the front end first, eligibility verification and clean claim rate, because that's where the fastest and largest improvement usually starts. Starting at the back end, chasing aged claims, means starting at the wrong end of the chain, and it's the mistake most practices make when they're under pressure to show a quick fix.

Patient responsibility is a bigger piece of this picture every year. Insured patients in 2025 were responsible for 7.3% of their total bills, up from 6.8% in 2024, and they paid a smaller share of what they owed: median bad debt rate rose from 1.1% to 1.3% over that same stretch. Point-of-service collection and upfront cost estimates carry real weight against that trend, and practices that skip them are leaving a growing share of revenue to chance.

None of these eight numbers matters sitting in a report nobody reads. The value sits in the cadence: checking them on a fixed schedule inside the practice management system, not once a quarter when someone remembers.

What payer intelligence and AI-backed denial management change about AR performance

Payers are using AI to deny claims faster than practices can appeal them, and that asymmetry is the central problem of 2026. The AMA's 2025 Prior Authorization Survey found algorithmic denial rates running 40% higher than human-reviewed decisions, and the AHA reported hospitals spent nearly $18 billion overturning denials in 2025 alone.

Denial rates aren't uniform across payers, and treating them as if they were is where a lot of appeal strategy goes wrong. Medicare Advantage initial denial rates have been estimated to average notably higher than the overall industry figure. Commercial payer initial denials have been estimated at a comparably elevated rate. UnitedHealthcare led commercial denial rates at roughly 15.6% in industry survey data. A practice that appeals every denial the same way, regardless of payer, is fighting the wrong battle with the wrong tools.

Knowing how each payer actually behaves, which documentation triggers a CO-50, which modifier combination sets off a bundling edit, and which appeal language actually gets a reversal is knowledge that compounds across every billing cycle a practice runs, making it more valuable the longer it accumulates. That knowledge is also fragile. When a biller who's carried that institutional memory for years leaves, it walks out the door with them, and a practice that leans on individual staff rather than documented, payer-specific workflows restarts from zero with every departure.

AI-backed denial management earns its place here by doing something software alone doesn't: machine pattern recognition surfaces denial trends across payer, CPT, and modifier combinations faster than any individual biller could track by hand, scanning volumes no person reviews claim by claim. Human judgment still handles what the machine surfaces: payer-specific appeal language, peer-to-peer escalation, documentation gap remediation. The combination closes the response gap, so every denial gets worked the moment it lands instead of sitting in a queue for the next monthly review.

None of this works if it requires tearing out a practice's existing systems. Integration with the EMR and clearinghouse already in place is what makes the intelligence usable without forcing an operational rebuild on top of everything else.

Sequencing AR improvement efforts so each fix builds on the last

AR days is the last number to move, which makes it the last place to intervene, not the first. Fix the sequence upstream to downstream and each step compounds the one before it. Fix it backward and a practice spends months chasing balances that were never going to move without the upstream repair.

Start with accurate measurement, before any operational change gets made. Strip patient bad debt and liens out of the AR calculation so the number reflects billing performance, not collections risk that was never recoverable. Stop resetting claim age on resubmission: the original aged date is the real data, and pretending otherwise just hides the problem from whoever's reviewing it. Establish a baseline broken out by payer, provider, and specialty, because AR problems rarely distribute evenly across a practice. A large majority of a practice's 90-plus-day balances might trace back to two payers and one specialty, and that tells you exactly where the next round of work needs to go.

From there, the sequence runs where the failure points actually sit: eligibility verification before the visit, coding audits before submission, authorization checks built into scheduling, documentation templates tied to payer criteria, and a weekly review cadence that catches denial patterns before they become 90-day balances. Each fix closes a specific gap identified in the root-cause data, and the AR days figure moves only once enough of those upstream gaps have closed. Chasing the aggregate number directly, without doing this work first, is why so many practices sit inside the MGMA benchmark on paper while still bleeding revenue in claims nobody's tracking closely enough.